⚠ Official Notice: www.ijisrt.com is the official website of the International Journal of Innovative Science and Research Technology (IJISRT) Journal for research paper submission and publication. Please beware of fake or duplicate websites using the IJISRT name.



Phyto-Constituents of Capsicum Based Nanoparticles for the Treatment of Psoriasis


Authors : Riya; Nikita Kaushik; Parveen Kumari; Sushila

Volume/Issue : Volume 11 - 2026, Issue 11 - November


Google Scholar : https://tinyurl.com/pje99syh

DOI : https://doi.org/10.38124/ijisrt/26nov488

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Psoriasis is a lifelong, immune-mediated inflammatory skin condition clinically defined by excessive keratinocyte hyperproliferation, profound extravascular dermal angiogenesis, and heavy leukocyte infiltration through the layers of cutaneous tissue [1]. Conventional topical and systemic medications often exhibit severe adverse effects, low drug bioavailability, and significant physical effects to enhance transdermal drug penetration [2]. Nowadays, herbal bioactive components from Capsicum species primarily focused on capsaicinoids, carotenoids, and flavonoids have attracted tremendous medical interest as potential healing agents due to their potent anti-inflammatory, antioxidant, and antiproliferative activities [3]. Although, their medical translation is significantly limited by high lipophilicity, severe local skin infection, and speedy systemic clearance [4]. Higher nanotechnology-primarily based delivery methods including strong lipid nanoparticles, polymeric nanogels, nano emulsions, steel/metallic-oxide green-synthesized nanoparticles offer a remarkable opportunity to cross these pharmacological roadblocks [5]. This exhaustive review offers an in-intensity, multifaceted evaluation of Capsicum phytochemistry, the pathophysiological rationale for focus on psoriasis, higher components techniques, mechanistic opinions, and translational clinical prospects documented number one medical literature [6].

References :

  1. Biancheri, P., et al. (2015). Immunology of psoriasis and inflammatory skin problems. journal of Investigative Dermatology, a hundred thirty five(2), 345–352.
  2. Krueger, G., et al. (2020). healing management of continual plaque psoriasis. New England journal of medication, 323(20), 1945–1952.
  3. Yadav, T. (2024). Treatment of psoriasis with herbal components and nano-companies. Bio Impacts, 14(3), 112–128.
  4. Bernstein, J. E., et al. (1986). results of topically carried out capsaicin on average and intense psoriasis vulgaris. magazine of the Yankee Academy of Dermatology, 15(3), 504–507.
  5. Parveen, S. R. (2026). dealing with psoriasis with Nature: A guide to Medicinal plant life. Intech Open, 1(1), 1–25.
  6. Ellis, C. N., et al. (1993). A twin blind evaluate of topically administered capsaicin in pruritic psoriasis. journal of the Yankee Academy of Dermatology, 29(3), 438–442.
  7. Raval, okay., et al. (2025). Bio-stimulated inexperienced Synthesis of Nanoparticles for Psoriasis treatment. Asian journal of inexperienced Chemistry, 9(four), 373–403.
  8. Guzmán, I., & Bosland, P. W. (2017). Sensory houses of Capsicum species and phytochemical characterization. meals Chemistry, 221, 1030–1037.
  9. Materska, M. (2014). Bioactive compounds in Capsicum fruits: Phenols, flavonoids and antioxidant pastime. Nutrition, 6(8), 3241–3258.
  10. Orellana-Escobedo, L., et al. (2013). Carotenoids and capsaicinoids in chili peppers. journal of Agricultural and meals Chemistry, sixty one(12), 2912–2918.
  11. Srinivasan, k. (2016). organic sports of chili peppers (Capsicum species) and their lively materials. essential Reviews in food technological know-how and nutrition, 56(7), 1072–1096.
  12. Luo, X., et al. (2021). Phytochemical ingredients and organic homes of domesticated Capsicum species. Molecules, 26(18), 5520–5535.
  13. Szallasi, A., & Blumberg, P. M. (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacological reviews, fifty one(2), 159–212.
  14. Holzer, P. (1991). local effector functions of capsaicin-touchy sensory nerve endings. Neuroscience, 48(4), 739–768.
  15. Roper, J., et al. (2018). Topical capsaicin in dermatology: Mechanism of motion and clinical application. Dermatologic therapy, 31(four), e12613.
  16. Pazar, N., et al. (2012). Medicinal plant life within the treatment of psoriasis. skin Pharmacology and body structure, 25(4), 162–169.
  17. Müller, M., et al. (2019). Oxidative pressure and antioxidant therapy in psoriasis. journal of Dermatological technology, ninety four(2), one hundred forty–149.
  18. Keck, C. M., & Müller, R. H. (2006). Nanostructured lipid vendors (NLC) as a singular transport machine for topical utility. European magazine of Pharmaceutics and Biopharmaceutics, sixty two(2), 149–157.
  19. Bodmeier R. (1995). Polymeric nanoparticles and nanogels in dermal drug transport. expert Opinion on therapeutic Patents, 5(8), 811–820.
  20. Kreuter, J. (2004). Nanoparticles—a historical attitude. international journal of Pharmaceutics, 270(1-2), three–10.
  21. Agnihotri, S. A., et al. (2004). recent advances on chitosan-based micro- and nanoparticles in drug delivery. magazine of managed release, one hundred(1), five–28.
  22. Lawrence, M. J., & Rees, G. D. (2000). Microemulsion-based totally media as novel drug transport structures. superior Drug transport evaluations, forty five(1), 89–121.
  23. Mittal, G., et al. (2020). Nano emulsions: An efficient method for focused pores and skin transport of therapeutics. Colloids and Surfaces B: Bio interfaces, 188, 110756.
  24. Sharma, A., et al. (2024). inexperienced synthesis of silver nanoparticles the use of plant extracts for biomedical purposes. substances science and Engineering: C, 134, 112678.
  25. Patra, J. ok. et al. 2018. green synthesis of steel nanoparticles via plant extracts and their biological packages. Biotechnology Advances, 36(8): 2133-2150.
  26. Lowes, M. A. et al. 2007. Pathogenesis of psoriasis. Annual overview of Immunology, 25: 407-435.
  27. Nestle, F. O. et al. 2009. Psoriasis. New England magazine of drugs, 361(5): 496-509.
  28. Griffiths, C. E. M. and Barker, J. N. W. N. 2007. Pathogenesis and clinical functions of psoriasis. The Lancet, 370(9583): 263-271.
  29. Schön, M. P. and Boehncke, W. H. 2005. Psoriasis. New England magazine of medication, 352(18): 1899-1912.
  30. Boehncke, W. H. and Schön, M. P. 2015. Psoriasis. The Lancet, 386(9997): 983-994.
  31. Armstrong, A. W. and study, C. 2020. Pathophysiology, scientific presentation, and treatment of psoriasis. JAMA, 323(19): 1945-1960.
  32. Menter, A. et al. 2019. hints of take care of the management of psoriasis and psoriatic arthritis. magazine of the American Academy of Dermatology, eighty(3): 773-795.
  33. Langley, R. G. et al. 2005. Psoriasis: Epidemiology, scientific features, and systemic treatment. Annals of the Rheumatic sicknesses, 64(supply 2): ii18-ii23.
  34. Chiang, C. C. et al. 2013. Antioxidant properties of Capsicum extracts in dermal irritation. journal of Ethnopharmacology, 148(2): 487-495.
  35. Howard, L. R., et al. (2000). Antioxidant potential and phenolic content material in peppers as stricken by maturity and species. magazine of Agricultural and meals Chemistry, 48(3), 624–631.
  36. Marin, A., et al. (2004). variations in carotenoid and capsaicin contents in chili peppers. magazine of Agricultural and meals Chemistry,52(15), 4857–4864.
  37. Conforti, F., et al. (2007). Capsicum species: Antioxidant and anti inflammatory sports. meals Chemistry, 104(4), 1572–1579.
  38. Prasad, B. C., et al. (2006). anti inflammatory results of capsaicinoids in cutaneous fashions. EU journal of Pharmacology, 530(1-2), 158–165.
  39. Kawada, T., et al. (1988). results of capsaicin on lipid metabolism and inflammation. journal of nutrition, 118(1), 22–28.
  40. Zhang, X., et al. (2022). Nanocarrier-primarily based herbal drug transport for psoriasis therapy. international journal of Pharmaceutics, 614, 121450.
  41. Kumar, R., et al. (2023). Lipid-based nanocarriers for dermal drug delivery: contemporary popularity and destiny prospects. journal of controlled release, 352, 450–472.
  42. Gupta, M., et al. (2021). Phytochemical-loaded nanoparticles in dermatology. Phytomedicine,85, 153540.
  43. Singh, V., et al. (2022). green nanotechnology in pharmaceutical drug transport. Nanoscale, 14(10), 3800–3820.
  44. Verma, D. D., et al. (2003). coaching and characterization of stealth lipid nanoparticles as drug carriers. magazine of controlled release,85(1-3), 233–240.
  45. Mezei, M., & Kulasekhara, V. (1980). Liposomes—a selective drug transport system for the topical direction of management. magazine of Pharmacy and Pharmacology, 32(1), 666–667.
  46. Pouton C. W. (2006). method of lipid-primarily based shipping structures for oral and topical management. EU journal of Pharmaceutical Sciences, 29(3-4), 278–287.
  47. Barry, B. W. (2001). Novel mechanisms and devices to permit a success transdermal drug shipping. EU magazine of Pharmaceutical Sciences, 14(2), one hundred and one–114.
  48. Benson, H. A. E. (2005). Transdermal drug shipping: Penetration enhancement strategies. cutting edge Drug delivery, 2(1), 23–33.
  49. Had graft, J. (1999). Passive enhancement techniques in topical and transdermal drug shipping. international journal of Pharmaceutics, 184(1), 1–6.
  50. Schaefer, H., & Rademeyer, T. E. (1996). skin Barrier: suggestions of Percutaneous Absorption. Karger Publishers.
  51. Rolland, A., et al. (1993). website-particularly drug delivery to the skin the use of novel vendors. Pharmaceutical reviews, 10(12), 1738–1744.
  52. Touitou, E., et al. (2000). Ethosomes—novel vesicular vendors for more suitable shipping: Characterization and pores and skin penetration residences. magazine of managed release, sixty five(3), 403–418.
  53. Cevc, G., & Blume, G. (2001). New, rather green formulation of diclofenac for the topical, transdermal management in ultra deformable drug carriers, Transferosomes. Biochemical, Biophysical Acta, 1564(1), 18–30.
  54. El Maghraby, G. M., et al. (2008). Liposomes and pores and skin: From drug shipping to model membranes. ecu magazine of Pharmaceutics and Biopharmaceutics, sixty eight(2), 207–215.
  55. Tan, M. H., et al. (2011). Recent tendencies in liposomal drug delivery structures. Nanomedicine, 6(3), 519–542.
  56. 56.Alkilani, A. Z., et al. (2015). Transdermal drug delivery: progressive mechanisms and destiny potential. Pharmaceutics, 7(4), 438–474.
  57. Brown, M. B., et al. (2006). Dermal and transdermal drug shipping programs: recent and future perspectives. drug shipping,13(3), 175–187.
  58. Priessnitz, M. R., & Langer, R. (2008). Transdermal drug shipping. Nature Biotechnology, 26(11), 1261–1268.
  59. Roberts, M. S., et al. (2002). Topical and transdermal shipping: procedures, integration, and mathematical types. recent day Drug shipping, 1(1), 1–15.
  60. Walters, okay. A., & Had graft, J. (1993). Pharmaceutical pores and skin Penetration Enhancement. Marcel Dekker.
  61. Keith, A. D. (1983). Polymer-mediated dermal shipping constructions. Drug improvement and commercial Pharmacy, nine(four), 653–668.
  62. Sensible, D. L. (2000). manual of Pharmaceutical managed release technology. Marcel Dekker.
  63. Florence, A. T. (2005). Nanoparticles and microparticles as drug carriers. Pharmaceutical information, 12(three), 160–166.
  64. Kreuter, J. (1994). Colloidal Drug shipping structures. Marcel Dekker.
  65. Cuignet, O., et al. (2011). Pharmacokinetics of topical nanocarriers in psoriasis models. Experimental Dermatology, 20(five), 410–416.
  66. Wilschut, J., & Hoekstra, D. (2002). Membrane Fusion. CRC Press.
  67. Jain, A., et al. (2015). Chitosan-based nanocarriers for localized drug shipping. Carbohydrate Polymers, 131, 350–361.
  68. Sinha, V. R., et al. (2004). Chitosan-based totally microspheres as a drug transport machine. magazine of managed launch, ninety nine(2), 255–271.
  69. Agrawal, A., et al. (2019). Silk fibroin biomaterials for tissue engineering and drug delivery. advanced Drug delivery critiques, a hundred and forty, a hundred and ten–a hundred thirty five.
  70. Kundu, S. C., et al. (2008). organic silk fibroin proteins for drug delivery. progress in Polymer technology, 33(10), 998–1018.
  71. Vyas, S. P. & Khar, R. k. (2002). concentrated and managed Drug shipping: Novel carrier systems. CBS Publishers.
  72. Vyas, S. P., et al. (2006). layout of novel lipid-primarily based carriers for dermal transport. journal of Drug concentrated on, 14(5), 291–305.
  73. Rawat, M., et al. (2008). Lipid carriers: a versatile delivery automobile for proteins and peptides. biological & Pharmaceutical Bulletin, 31(eleven), 2045–2051.
  74. Muller, R. H., et al. (2002). strong lipid nanoparticles (SLN) and nanostructured lipid providers (NLC) for beauty and dermatological arrangements. advanced Drug delivery reviews, fifty four(supply 1), S131–S155.
  75. Jenning, V., et al. (2000). nutrition A loaded solid lipid nanoparticles for topical use: Drug release homes. magazine of managed release, sixty six(2-3), 115–126.
  76. Souto, E. B. & Muller, R. H. (2008). research of the elements affecting the incorporation of active ingredients in SLN and NLC. journal of Microencapsulation, 25(7), 443–452.
  77. Wissing, S. A. & Muller, R. H. (2003). cosmetic packages for strong lipid nanoparticles (SLN). international journal of beauty technological know-how, 25(1-2), 15–24.
  78. Westesen, k., et al. (1993). investigation of the physicochemical properties of lipid nanoparticles. international magazine of Pharmaceutics, 93(1-3), 189–199.
  79. Zur Muhle, A., et al. (1998). solid lipid nanoparticles (SLN) for managed drug delivery: Drug release and interplay with matrix lipids. ecu journal of Pharmaceutics and Biopharmaceutics, 45(2), 149–a hundred and fifty five.
  80. Bunjes, H., et al. 2001. strong lipid nanoparticles: a shut examine the lipid base and the drug incorporation mechanism. complicated Drug shipping studies, 47(1), 19–35.
  81. Gohla, S. R. & Dingler, A. 2001. the use of sturdy lipid nanoparticles (SLN) in cosmetic preparations. applied Microbiology and Biotechnology, fifty five(4), 395–401.
  82. Mehnert, W. & Mader, k. 2001. sturdy lipid nanoparticles: creation, characterization and packages. superior Drug delivery evaluations, forty seven(2-three), a hundred sixty five–196.
  83. Gasco, M. R. 1993. strong lipid nanoparticles for dermal transport. magazine of Pharmacy and Pharmacology, 45(6), 493–498.
  84. Trotta, M., et al. 2003. sturdy lipid nanoparticles as providers for topical management of tretinoin. international magazine of Pharmaceutics, 257(1-2), 87–ninety five.
  85. Cavalli, R., et al. 2006. sturdy lipid nanoparticles as carriers for hydrocortisone. worldwide journal of Pharmaceutics, 137(1), 89–96.

Psoriasis is a lifelong, immune-mediated inflammatory skin condition clinically defined by excessive keratinocyte hyperproliferation, profound extravascular dermal angiogenesis, and heavy leukocyte infiltration through the layers of cutaneous tissue [1]. Conventional topical and systemic medications often exhibit severe adverse effects, low drug bioavailability, and significant physical effects to enhance transdermal drug penetration [2]. Nowadays, herbal bioactive components from Capsicum species primarily focused on capsaicinoids, carotenoids, and flavonoids have attracted tremendous medical interest as potential healing agents due to their potent anti-inflammatory, antioxidant, and antiproliferative activities [3]. Although, their medical translation is significantly limited by high lipophilicity, severe local skin infection, and speedy systemic clearance [4]. Higher nanotechnology-primarily based delivery methods including strong lipid nanoparticles, polymeric nanogels, nano emulsions, steel/metallic-oxide green-synthesized nanoparticles offer a remarkable opportunity to cross these pharmacological roadblocks [5]. This exhaustive review offers an in-intensity, multifaceted evaluation of Capsicum phytochemistry, the pathophysiological rationale for focus on psoriasis, higher components techniques, mechanistic opinions, and translational clinical prospects documented number one medical literature [6].

Paper Submission Last Date
30 - November - 2026

SUBMIT YOUR PAPER CALL FOR PAPERS
Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe